Research ArticleAccepted Articles
Tocilizumab in Behcet's disease: a multicentre study of 30 patients
Mohamed-Yacine Khitri, Alessandra Bartoli, Georgina Maalouf, Alban Deroux, Carlo Salvarani, Giacomo Emmi, Omer Karadag, Gerard Espinosa, Mathilde Leclercq, Gabriele Simonini, Mathieu Vautier, Patrice Cacoub and David Saadoun
The Journal of Rheumatology March 2023, jrheum.221106; DOI: https://doi.org/10.3899/jrheum.221106
Mohamed-Yacine Khitri
Sorbonne Université, AP-HP, Hôpital Pitié Salpetrière, Department of Internal Medicine and Clinical Immunology France, Centre national de référence maladies Autoimmunes Systémiques rares, Centre national de référence maladies Autoinflammatoires et Amylose, and Inflammation-Immunopathology- Biotherapy Department (DMU i3), F-75013, Paris, France.
Alessandra Bartoli
Sorbonne Université, AP-HP, Hôpital Pitié Salpetrière, Department of Internal Medicine and Clinical Immunology France, Centre national de référence maladies Autoimmunes Systémiques rares, Centre national de référence maladies Autoinflammatoires et Amylose, and Inflammation-Immunopathology- Biotherapy Department (DMU i3), F-75013, Paris, France.
Georgina Maalouf
Sorbonne Université, AP-HP, Hôpital Pitié Salpetrière, Department of Internal Medicine and Clinical Immunology France, Centre national de référence maladies Autoimmunes Systémiques rares, Centre national de référence maladies Autoinflammatoires et Amylose, and Inflammation-Immunopathology- Biotherapy Department (DMU i3), F-75013, Paris, France.
Alban Deroux
Department of Internal Medicine, University Hospital of Grenoble, CS 10217, F-38043 Grenoble Cedex 09, France.
Carlo Salvarani
Division of Rheumatology, Azienda USL-IRCCS di Reggio Emilia, University of Modena and Reggio Emilia, Modena and Reggio Emilia, Italy.
Giacomo Emmi
Department of Experimental and Clinical Medicine, University of Florence, and Behçet Centre, Careggi University Hospital, Florence, Italy.
Omer Karadag
Division of Rheumatology, Department of Internal Medicine, Vasculitis Research Center, Hacettepe University School of Medicine, Ankara, Turkey.
Gerard Espinosa
Department of Autoimmune Diseases, Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, España
Mathilde Leclercq
CHU Rouen, Internal Medicine Department, F-76000 Rouen, France.
Gabriele Simonini
Rheumatology Unit, NEUROFARBA Department, Meyer Children's Hospital, University of Florence, Italy.
Mathieu Vautier
Sorbonne Université, AP-HP, Hôpital Pitié Salpetrière, Department of Internal Medicine and Clinical Immunology France, Centre national de référence maladies Autoimmunes Systémiques rares, Centre national de référence maladies Autoinflammatoires et Amylose, and Inflammation-Immunopathology- Biotherapy Department (DMU i3), F-75013, Paris, France.
Patrice Cacoub
Sorbonne Université, AP-HP, Hôpital Pitié Salpetrière, Department of Internal Medicine and Clinical Immunology France, Centre national de référence maladies Autoimmunes Systémiques rares, Centre national de référence maladies Autoinflammatoires et Amylose, and Inflammation-Immunopathology- Biotherapy Department (DMU i3), F-75013, Paris, France.
David Saadoun
Sorbonne Université, AP-HP, Hôpital Pitié Salpetrière, Department of Internal Medicine and Clinical Immunology France, Centre national de référence maladies Autoimmunes Systémiques rares, Centre national de référence maladies Autoinflammatoires et Amylose, and Inflammation-Immunopathology- Biotherapy Department (DMU i3), F-75013, Paris, France.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Accepted manuscript
Tocilizumab in Behcet's disease: a multicentre study of 30 patients
Mohamed-Yacine Khitri, Alessandra Bartoli, Georgina Maalouf, Alban Deroux, Carlo Salvarani, Giacomo Emmi, Omer Karadag, Gerard Espinosa, Mathilde Leclercq, Gabriele Simonini, Mathieu Vautier, Patrice Cacoub, David Saadoun
The Journal of Rheumatology Mar 2023, jrheum.221106; DOI: 10.3899/jrheum.221106
Accepted manuscript
Tocilizumab in Behcet's disease: a multicentre study of 30 patients
Mohamed-Yacine Khitri, Alessandra Bartoli, Georgina Maalouf, Alban Deroux, Carlo Salvarani, Giacomo Emmi, Omer Karadag, Gerard Espinosa, Mathilde Leclercq, Gabriele Simonini, Mathieu Vautier, Patrice Cacoub, David Saadoun
The Journal of Rheumatology Mar 2023, jrheum.221106; DOI: 10.3899/jrheum.221106